Skip to content

Sedative and Hypnotic Effects Induced by EA

EA Induces Sedative and Hypnotic Effects by Detecting BIS Value and MRI.

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01896063
Enrollment
45
Registered
2013-07-11
Start date
2011-09-30
Completion date
2014-05-31
Last updated
2014-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bypass Complications

Keywords

Electroacupuncture, Sedation

Brief summary

Insomnia is a common clinical disease.The serious patients could not sleep all night, often accompanied by headache, dizziness, forgetfulness and so on. All of these increase the mental burden of insomnia patients and seriously affected the normal work and quality of life of patients. Modern medical treatment to treat insomnia is using sedative and hypnotic drugs, mainly benzodiazepine, zopiclone. But long-term use of these drugs can induce the adverse reactions, including resistance, dependence and addiction. Many articles indicate that electroacupuncture can effectively improve insomnia, play the role of sedative and hypnotic effect and avoid many adverse reactions and side effects. Then there are no more objective indicators to affirm that which part of brain takes place the appropriate changes when electroacupuncture induces the sedative effect. So we designed this experiment.

Interventions

PROCEDUREElectroacupuncture

Sponsors

Xijing Hospital
Lead SponsorOTHER

Study design

Intervention model
CROSSOVER
Primary purpose
PREVENTION
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
24 Years to 35 Years
Healthy volunteers
Yes

Inclusion criteria

* Must be able to go with EA * Can not have any disease

Exclusion criteria

* Overworked recently

Design outcomes

Primary

MeasureTime frameDescription
BIS value30 minutesThe primary outcome is assessing whether BIS value reduce during electroacupuncture stimulation.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 10, 2026